rs78442416
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP2BP4_StrongBP6_Very_StrongBS2
The NM_012156.2(EPB41L1):c.1934G>A(p.Arg645Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000385 in 1,614,086 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_012156.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPB41L1 | NM_012156.2 | c.1934G>A | p.Arg645Gln | missense_variant | 15/22 | ENST00000338074.7 | NP_036288.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPB41L1 | ENST00000338074.7 | c.1934G>A | p.Arg645Gln | missense_variant | 15/22 | 1 | NM_012156.2 | ENSP00000337168 | P5 |
Frequencies
GnomAD3 genomes AF: 0.000618 AC: 94AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00107 AC: 268AN: 251256Hom.: 0 AF XY: 0.000957 AC XY: 130AN XY: 135848
GnomAD4 exome AF: 0.000361 AC: 527AN: 1461826Hom.: 1 Cov.: 33 AF XY: 0.000352 AC XY: 256AN XY: 727228
GnomAD4 genome AF: 0.000617 AC: 94AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.000658 AC XY: 49AN XY: 74450
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jan 29, 2017 | - - |
EPB41L1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 01, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at